Business Context and Reporting Period
This Form 8-K Current Report was filed by Enochian Biosciences, Inc. (not Lunai Bioworks Inc.) on May 1, 2019. The registrant is incorporated in Delaware and maintains its principal executive offices in Los Angeles, California. The filing serves as a Regulation FD disclosure to make an investor presentation titled "Meet Enochian BioSciences" available to the public.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a presentation and does not contain audited financial statements or quantitative financial data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely announces the release of an investor presentation.
Guidance, Outlook, and Risks
- Management Commentary: The company has furnished an investor presentation (Exhibit 99.1) but explicitly states it undertakes no duty or obligation to update or revise the information contained in this report or the exhibit.
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, except as expressly set forth by specific reference.
- Emerging Growth Company Status: The registrant has indicated it is an emerging growth company.
Investor Verification Checklist
- Verify the correct registrant name is Enochian Biosciences, Inc., as the input metadata referenced "Lunai Bioworks Inc."
- Review the attached Exhibit 99.1 ("Meet Enochian BioSciences") for actual business updates, as the 8-K text itself contains no operational details.
- Note that the company explicitly disclaims any obligation to update the information provided in this filing.
- Confirm the company's status as an emerging growth company for applicable reporting exemptions.